药品注册申请号:017340
申请类型:NDA (新药申请)
申请人:VALEANT PHARMS NORTH
申请人全名:VALEANT PHARMACEUTICALS NORTH AMERICA LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 RETIN-A TRETINOIN CREAM;TOPICAL 0.1% Yes Yes AB 1973/01/26 Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2016/05/13 SUPPL-48(补充) Approval Manufacturing (CMC) STANDARD
2015/12/17 SUPPL-47(补充) Approval Manufacturing (CMC) STANDARD
2013/01/08 SUPPL-46(补充) Approval Manufacturing (CMC) STANDARD
2002/12/06 SUPPL-38(补充) Approval Manufacturing (CMC) STANDARD
2002/06/10 SUPPL-36(补充) Approval Labeling STANDARD
2002/06/10 SUPPL-33(补充) Approval Labeling STANDARD
2002/06/10 SUPPL-32(补充) Approval Labeling STANDARD
2001/03/20 SUPPL-37(补充) Approval Manufacturing (CMC) STANDARD
1999/01/25 SUPPL-35(补充) Approval Manufacturing (CMC) STANDARD
1998/07/23 SUPPL-34(补充) Approval Manufacturing (CMC) STANDARD
1992/01/24 SUPPL-30(补充) Approval Manufacturing (CMC) STANDARD
1990/08/28 SUPPL-28(补充) Approval Labeling
1990/08/28 SUPPL-27(补充) Approval Labeling
1990/07/03 SUPPL-29(补充) Approval Manufacturing (CMC) STANDARD
1989/12/01 SUPPL-26(补充) Approval Manufacturing (CMC) STANDARD
1989/04/12 SUPPL-25(补充) Approval Labeling
1986/08/26 SUPPL-23(补充) Approval Manufacturing (CMC) STANDARD
1986/07/24 SUPPL-21(补充) Approval Manufacturing (CMC) STANDARD
1985/06/11 SUPPL-22(补充) Approval Manufacturing (CMC) STANDARD
1984/03/30 SUPPL-20(补充) Approval Manufacturing (CMC) STANDARD
1983/06/06 SUPPL-19(补充) Approval Manufacturing (CMC) STANDARD
1982/12/13 SUPPL-17(补充) Approval Labeling
1981/07/28 SUPPL-18(补充) Approval Manufacturing (CMC) STANDARD
1978/12/04 SUPPL-15(补充) Approval Labeling
1977/01/04 SUPPL-14(补充) Approval Labeling
1976/06/30 SUPPL-13(补充) Approval Manufacturing (CMC) STANDARD
1974/08/27 SUPPL-10(补充) Approval Manufacturing (CMC) STANDARD
1974/04/15 SUPPL-9(补充) Approval Supplement STANDARD
1974/04/15 SUPPL-7(补充) Approval Supplement STANDARD
1973/01/26 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:TRETINOIN 剂型/给药途径:CREAM;TOPICAL 规格:0.1% 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
017340 001 NDA RETIN-A TRETINOIN CREAM;TOPICAL 0.1% Prescription Yes Yes AB Approved Prior to Jan 1, 1982 VALEANT PHARMS NORTH
075213 001 ANDA TRETINOIN TRETINOIN CREAM;TOPICAL 0.1% Prescription No No AB 1998/12/24 PADAGIS US
211645 001 ANDA TRETINOIN TRETINOIN CREAM;TOPICAL 0.1% Prescription No No AB 2019/01/22 TARO
218561 001 ANDA TRETINOIN TRETINOIN CREAM;TOPICAL 0.1% Prescription No No AB 2024/04/25 ZYDUS LIFESCIENCES
217804 001 ANDA TRETINOIN TRETINOIN CREAM;TOPICAL 0.1% Prescription No No AB 2024/04/29 ALEMBIC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database